Arvinas, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Arvinas, Inc. - overview
Established
2013
Location
New Haven, CT, US
Primary Industry
Pharmaceuticals
About
Founded in 2013 and based in Connecticut, US, Arvinas, Inc. is a biopharmaceutical company that develops protein degradation therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases.
Current Investors
Canaan Partners, 5AM Ventures, Connecticut Innovations
Primary Industry
Pharmaceuticals
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.arvinas.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Arvinas, Inc. - timeline of key events
Arvinas, Inc. - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 14,323,920 | 42,976,478 | 21,801,777 | 46,700,000 | 131,400,000 | - | - | - |
| % Revenue Growth (YoY) | - | 200.0% | (49.3%) | 114.2% | 181.4% | - | - | - |
| EBITDA (USD) | (43,078,115) | (49,256,463) | (120,832,971) | (188,900,000) | (253,200,000) | - | - | - |
| Operating Income (USD) | (43,802,078) | (51,524,514) | (124,857,477) | (195,300,000) | (263,200,000) | - | - | - |
| Operating Margin | (305.8%) | (119.9%) | (572.7%) | (418.2%) | (200.3%) | - | - | - |
| % EBITDA Margin | (300.7%) | (114.6%) | (554.2%) | (404.5%) | (192.7%) | - | - | - |
| NET Income (USD) | (41,480,466) | (70,292,227) | (119,332,064) | (191,000,000) | (282,500,000) | - | - | - |
| % Net Margin | (289.6%) | (163.6%) | (547.4%) | (409.0%) | (215.0%) | - | - | - |
Arvinas, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.